Digital Pathology Market Growth, Size, Analysis, Outlook by Trends, Growth Analysis and Forecast

Digital pathology fuses the procurement, management, sharing and translation of pathology data – including slides and information – in a digital climate. Digital slides are made when glass slides are captured with a scanning gadget, to give a high-goal digital picture that can be seen on a PC screen or cell phone.

Global digital pathology Market size was $736 billion in 2021, and is anticipated to grow to a value of more than $1873 billion by 2030, registering a growing CAGR (Compound annual growth rate) of over 13% from 2022 to 2030.

Key market trends- Growth determinants and restraints

The rising predominance of cancer is the main consideration speeding up the development of the digital pathology market. Besides, increasing reception of digital pathology to improve lab productivity and widespread utilizations of advanced pathology in drug improvement and companion diagnostics are likewise expected to drive the progression of the digital pathology market. Nonetheless, significant expenses engaged with the digital pathology frameworks controls the digital pathology market. Also absence of prepared pathologists will further impede market development.

In addition, introduction of developing interest of customized medication and reasonable scanners for private pathology practices will set out more than adequate open doors for the digital pathology market.

Request a Free Sample Copy

Segmentation Analysis of Global digital pathology Market

Based on product –

• Software
• Device -Scanners, and Slide Management System
• Storage System

The device section leads the market in 2021 and represented the biggest income share of over 50% in 2021. The device segment incorporates scanner and slide the executives’ frameworks. Expanding reception for academic research activities and upgraded goal are the key development drivers of the section.

Based on application –

• Drug discovery and development
• Academic research
• Disease diagnosis- cancer cell detection

The academic research application segment represented the biggest share of over 45% of the worldwide income in 2021 and is projected to grow further at a consistent CAGR from 2022 to 2030.

Based on end-user –

• Hospitals
• Biotech & Pharma Companies
• Diagnostic Labs
• Academic & Research Institutes

The hospitals segment represented the biggest income share of over 36% in 2021 attributable to the high reception of digital scanning techniques in emergency clinics for quicker analysis and better persistent consistence.

North America is anticipated to hold the largest market share

North America, Europe, Latin America, Asia Pacific, and Middle East and Africa are the major regions constituting the geographical landscape of Global digital pathology Market. North America held the largest share of the digital pathology market in 2020 and is expected to grow further. The rising pervasiveness of chronic diseases, growing interest for quality diagnostics, the presentation of ideal repayment policies, and the execution of positive drives by the legislatures in the US and Canada are main considerations driving the development of the digital pathology market in North America.

Competitive Landscape

The Key players in the Global digital pathology Market are Leica Biosystems, Koninklijke Philips N.V, 3D-Histech Ltd, Apollo Enterprise Imaging, F. Hoffmann-La Roche Ltd, Visiopharm A/S, Hamamatsu Photonics K.K, Corista, Ventana Medical Systems, Inc, and Huron Digital Pathology Inc.

Major development

• In April 2021, Leica Biosystems joined forces with Paige to coordinate its digital pathology stage with the last’s AI-empowered research oncology programming. This would stretch out admittance to computational pathology items for translational and clinical in select nations across the North America and Europe locales.
• Likewise in April 2021, Philips banded together with Ibex Medical Analytics to consolidate its digital pathology solutions with the latter’s AI-fueled Galen stage, hence improving its contributions. While Oxford University Hospitals Cellular Pathology department finished 100 percent digitization of histology slides with the assistance of Philips.

Interested in purchasing this Report? Click here

Major questions answered in this report

• What is the growth rate of this Market?
• What are the primary growth determinants of this Market?
• Which are the major regions constituting the geographical landscape of this Market?
• Which are the prominent companies operating in this Market?

Key takeaways from the report-

• This Market registers a CAGR of over 13% over 2022-2030.
• The market in North America is projected to witness the highest growth rate during the forecast period (2021–2030).
• the device segment holds the largest market share.
• The rising predominance of cancer disease is the main consideration speeding up the development of this market.

About We Market Research

We Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. We Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.